PD-L2 Recombinant Antibody [TY25] (OAAV00917)

Produktübersicht

• Artikelname: PD-L2 Recombinant Antibody [TY25] (OAAV00917)
• Artikelnummer: ASB-OAAV00917
• Hersteller Artikelnummer: OAAV00917
• Alternativnummer: ASB-OAAV00917-200UG
• Hersteller: Aviva
• Wirt: Rat
• Kategorie: Proteine/Peptide
• Applikation: Blocking, FC, IF
• Spezies Reaktivität: Mouse
• Immunogen: This antibody was raised by immunising rats with a soluble recombinant TL1A (T77-L252):Fc protein.
• Alternative Synonym: bM20K13.3 (tumor necrosis factor (ligand) superfamily, member 15),TL,Tl1,Tl1a,TNF ligand-related molecule 1,Tnlg1b,tumor necrosis factor ligand 1b,tumor necrosis factor ligand superfamily member 15,vascular endothelial cell growth inhibitor,vascular endothelial growth inhibitor,VE,Vegi.

Produktbeschreibung

This reformatted rat antibody was made using the variable domain sequences of the original Rat IgG format, for improved compatibility with existing reagents, assays and techniques.

Produkteigenschaften

• Klonalität: Monoclonal
• Klon-Bezeichnung: [TAN2-2]
• NCBI: 326623
• UniProt: P60033
• Formulierung: PBS with 0.02% Proclin 300.

Anwendungsbeschreibung

• Application Verdünnung: Receptor for TNFRSF25 and TNFRSF6B. Mediates activation of NF-kappa-B. Inhibits vascular endothelial growth and angiogenesis (in vitro). Promotes activation of caspases and apoptosis (By similarity). Promotes splenocyte alloactivation.